🔎 Trials Near Me

Gara Jalqabaatti › Saree (Gosoota Hunda) › Michigan › Grand Rapids

Qorannoo klinikaalii Saree (Gosoota Hunda) Grand Rapids, MI keessatti

Qorannoo 28 Saree (Gosoota Hunda) f Grand Rapids fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)

Namoota walitti qabaa jiraSadarkaa 2
  • START Midwest ( Site 1103), Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07209111

REC-7735 in Participants With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • START Midwest, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07819136

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

Namoota walitti qabaa jiraSadarkaa 1
  • START Midwest /ID# 279035, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07409246

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Corewell Health ( Site 4001), Grand Rapids
1 Month – 17 Years · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07630974

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
  • Start Midwest, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06150157

A Study of JNJ-87890387 for Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Start Midwest, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06178614

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Cancer And Hematology Centers Of Western Michigan - Grand Rapids /ID# 279955, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07365241

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Cancer Research Consortium of West Michigan, Grand Rapids
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT02693535

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • START Midwest, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06128551

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Corewell Health ( Site 3001), Grand Rapids
1 Month – 17 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06941272

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Namoota walitti qabaa jiraSadarkaa 1
  • START - Midwest Cancer Research Center, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06253871

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • The Cancer & Hematology Centers, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06119581

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

Namoota walitti qabaa jiraSadarkaa 3
  • Cancer and Hematology Centers of Western Michigan, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06252649

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

Namoota walitti qabaa jiraSadarkaa 1
  • START Midwest, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07321106

Project: Every Child for Younger Patients With Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
  • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
  • Trinity Health Grand Rapids Hospital, Grand Rapids
Hanga umuriin 25 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT02402244

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Site 04, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT07276373

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • START Midwest, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT06759649

A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • START Midwest, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06880549

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
  • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06580314

A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer

Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
  • BAMF Health Inc., Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07258836

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • START Midwest, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT05768139

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

Namoota walitti qabaa jiraSadarkaa 1
  • GSK Investigational Site, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Wax-2026 · NCT06431594

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Namoota walitti qabaa jiraSadarkaa 1
  • Context Investigational Site, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Wax-2026 · NCT06756035

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • START Midwest, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Cam-2026 · NCT07094204

A Study of YL242 in Subjects With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • US-206, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Mud-2025 · NCT07197827

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Corewell Health, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Wax-2025 · NCT05768269

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Namoota walitti qabaa jira
  • Mercy Health Saint Mary's, Grand Rapids
  • Spectrum Health at Butterworth Campus, Grand Rapids
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Sad-2024 · NCT03860883

Qorannoo Saree (Gosoota Hunda) magaalota biroo keessatti

Qorannoo biroo Grand Rapids keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.